Annual Total Liabilities
$53.09 M
+$24.99 M+88.93%
31 December 2021
Summary:
Concert Pharmaceuticals annual total liabilities is currently $53.09 million, with the most recent change of +$24.99 million (+88.93%) on 31 December 2021. During the last 3 years, it has risen by +$24.99 million (+88.93%).CNCE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$37.86 M
-$10.74 M-22.10%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly total liabilities is currently $37.86 million, with the most recent change of -$10.74 million (-22.10%) on 30 September 2022.CNCE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +88.9% | +30.4% |
| 5 y5 years | +114.0% | +15.8% |
CNCE Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -65.0% | -75.1% |
Concert Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $37.86 M(-22.1%) |
| June 2022 | - | $48.60 M(-8.0%) |
| Mar 2022 | - | $52.84 M(-0.5%) |
| Dec 2021 | $53.09 M(+88.9%) | $53.09 M(+82.8%) |
| Sept 2021 | - | $29.05 M(+11.8%) |
| June 2021 | - | $25.99 M(+0.1%) |
| Mar 2021 | - | $25.95 M(-7.6%) |
| Dec 2020 | $28.10 M(-22.0%) | $28.10 M(+10.5%) |
| Sept 2020 | - | $25.43 M(-8.9%) |
| June 2020 | - | $27.91 M(-14.9%) |
| Mar 2020 | - | $32.80 M(-8.9%) |
| Dec 2019 | $36.01 M(+45.2%) | $36.01 M(+10.2%) |
| Sept 2019 | - | $32.69 M(-0.6%) |
| June 2019 | - | $32.90 M(-2.1%) |
| Mar 2019 | - | $33.59 M(+35.4%) |
| Dec 2018 | $24.81 M(+62.1%) | $24.81 M(+8.8%) |
| Sept 2018 | - | $22.80 M(+12.7%) |
| June 2018 | - | $20.23 M(+17.3%) |
| Mar 2018 | - | $17.25 M(+12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $15.30 M(+3.4%) | $15.30 M(-6.5%) |
| Sept 2017 | - | $16.37 M(-63.0%) |
| June 2017 | - | $44.24 M(+215.8%) |
| Mar 2017 | - | $14.01 M(-5.3%) |
| Dec 2016 | $14.80 M(-9.2%) | $14.80 M(-8.8%) |
| Sept 2016 | - | $16.22 M(-1.4%) |
| June 2016 | - | $16.45 M(+9.4%) |
| Mar 2016 | - | $15.03 M(-7.8%) |
| Dec 2015 | $16.30 M(-45.0%) | $16.30 M(-6.3%) |
| Sept 2015 | - | $17.39 M(-15.0%) |
| June 2015 | - | $20.46 M(-17.7%) |
| Mar 2015 | - | $24.87 M(-16.1%) |
| Dec 2014 | $29.63 M(-80.5%) | $29.63 M(-9.5%) |
| Sept 2014 | - | $32.73 M(-3.7%) |
| June 2014 | - | $34.00 M(-6.7%) |
| Mar 2014 | - | $36.43 M(-76.0%) |
| Dec 2013 | $151.88 M(+8.6%) | $151.88 M(+256.2%) |
| Sept 2013 | - | $42.64 M(-69.5%) |
| Dec 2012 | $139.82 M(+2.7%) | $139.82 M |
| Dec 2011 | $136.12 M | - |
FAQ
- What is Concert Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual total liabilities?
The current annual total liabilities of CNCE is $53.09 M
What is the all time high annual total liabilities for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual total liabilities is $151.88 M
What is Concert Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of CNCE is $37.86 M
What is the all time high quarterly total liabilities for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly total liabilities is $151.88 M